Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “MEREO BIOPHARMA 5, INC.”

4 pharma patents match "MEREO BIOPHARMA 5, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 4
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 4 pharmaceutical patents matching "MEREO BIOPHARMA 5, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

4 results for “MEREO BIOPHARMA 5, INC.” · 30,257 patents in full index Clear search

  1. US 11512128

    VEGF/DLL4 binding agents and uses thereof

    MEREO BIOPHARMA 5, INC. · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted

  2. US 11339213

    Methods and compositions for treatment of cancer

    MEREO BIOPHARMA 5, INC. · Granted May 24, 2022 · Expires May 19, 2042

    granted

  3. US 11230596

    Methods for treatment of cancer comprising TIGIT-binding agents

    MEREO BIOPHARMA 5, INC. · Granted Jan 25, 2022 · Expires Jan 20, 2042

    granted

  4. US 11136384

    Methods for treatment of cancer comprising TIGIT-binding agents

    MEREO BIOPHARMA 5, INC. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.